MedStar Research Institute — Washington D.C., District of Columbia

MedStar Research Institute is a clinical research site located in Washington D.C., District of Columbia, United States 20003.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

MedStar Research Institute has participated in 9 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2, Diabetes Type 2, Soft Tissue Sarcoma.

Sponsors: VeraLight, Inc., Novo Nordisk A/S, Alaunos Therapeutics.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MedStar Research Institute?

MedStar Research Institute has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MedStar Research Institute conducted?

MedStar Research Institute has 9 clinical trials on record. Their work covers Diabetes Mellitus, Type 2, Diabetes Type 2, Soft Tissue Sarcoma.

Is MedStar Research Institute accredited by Crixeo Health?

Yes — MedStar Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about MedStar Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.